Evaluation of the PADUA Prediction Score in Vein Thromboembolism Prophylaxis in Patients Admitted to Imam Reza Hospital in 2017

Padua prediction score (PPS) predicts high risk patients of vein thromboembolism (VTE). This study was conducted to assess Padua prediction score in order to receive prophylaxis of VTE. This prospective cohort study was conducted between 300 patients admitted to the internal ward of Imam Reza Hospital who stayed longer than three days in 2017. The initial questionnaire of PPS done for patients and telephone follow up after three months was used to gather data. For the statistical analysis, SPSS software version 22 using chi-square test was used. Out of 300 patients, according to the Padua model, 266 patients were in a high risk of VTE, 35 received prophylaxis. Only 13.15% of high risk groups received prophylaxis. Around 87% of high risk groups did not receive prophylaxis. After six months follow up, 18 patients got VTE, three of them being in a high-risk group and received prophylaxis. There was a significant difference between PPS and cancer in receiving prophylaxis (P < 0.05). Receiving prophylaxis in the high-risk group was low. Cancer patients needed more in receiving prophylaxis, according to categories of cancer/not cancer, however, they did not receive it and PPS could recognize them.